Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation |
| |
Authors: | Kühn Markus C Willenberg Holger S Schott Matthias Papewalis Claudia Stumpf Ulla Flohé Sascha Scherbaum Werner A Schinner Sven |
| |
Affiliation: | a Department of Endocrinology, Diabetes and Rheumatology, University Hospital Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany b Department of Traumatology and Handsurgery, University Hospital Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany |
| |
Abstract: | Several studies have reported a positive relationship of the body fat mass and bone density. However, it is not clear whether adipocyte-derived signaling molecules directly act on osteoblasts or osteoclasts. Therefore, we investigated the effect of fat cell-secreted factors on the proliferation and differentiation of preosteoblasts and the molecular mechanisms involved.This stimulation led to an increased proliferation of MC3T3-E1 and primary preosteoblastic cells (2.8-fold and 1.5-fold, respectively; p < 0.0001), which could be reduced with inhibitors of protein tyrosine kinases, FGFR1 and PI3K. Concordantly, we found human adipocytes to secrete bFGF and bFGF to mimic the effect of adipocyte-secreted factors. The ratio of OPG/RANKL secretion in primary human preosteoblasts increased 9-fold (mRNA and protein) when stimulated with adipocyte-secreted factors. Moreover, osteoblasts which were prestimulated with adipocyte-secreted factors inhibited the formation of osteoclasts.In conclusion, human adipocytes secrete factors that directly act on preosteoblasts and alter their crosstalk with osteoclasts. These in vitro findings reflect the higher bone mass in obese people and attribute it to effects of adipocyte-secreted factors on bone formation. |
| |
Keywords: | ALP, Alkaline phosphatase bFGF, Basic fibroblast growth factor BMI, Body mass index BMD, Bone mineral density CM, Control medium DKK, Dickkopf EGF, Epidermal growth factor FCCM, Fat-cell conditioned-medium FGFR1, Fibroblast growth factor receptor type 1 JAK, Janus kinase LRP, Low density lipoprotein receptor-related protein M-CSF, Macrophage colony-stimulating factor MEK, MAPK/ERK kinase OPG, Osteoprotegerin PDGF, Platelet-derived growth factor PI3K, Phosphatidylinositol-3-kinase PKA, Protein kinase A RANK, Receptor activator of nuclear factor kappa B RANKL, Receptor activator of nuclear factor kappa B ligand SFRP, Secreted frizzled-related protein TRAP, Tartrate-resistant acid phosphatase |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|